Today's Hours: 8:00am - 6:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    edited by Robert A. Britton, Baylor College of Medicine, Molecular Virology and Microbiology, ... Show More Houston, Texas, Patrice D. Cani, Université catholique de Louvain, Louvain Drug Research Institute, WELBIO-Walloon Excellence in Life Sciences, Brussels, Belgium.
    Summary: Examining the enormous potential of microbiome manipulation to improve health.

    Contents:
    A. TRADITIONAL PROBIOTIC APPROACHES. Chapter 1. Biochemical features of beneficial microbes : foundations for therapeutic microbiology / Melinda A. Engevik, James Versalovic
    Chapter 2. The genomic basis of lactobacilli as health-promoting organisms / Elisa Salvetti, Paul W. O'Toole
    Chapter 3. Bifidobacteria and their health-promoting effects / Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles
    B. NEXT-GENERATION BACTERIOTHERAPY: OPPORTUNITIES IN CHRONIC DISEASES. Chapter 4. Microbial interactions and interventions in colorectal cancer / Terence van Raay, Emma Allen-Vercoe
    Chapter 5. Microbial impact on host metabolism: opportunities for novel treatments of nutritional disorders? / Hubert Plovier, Patrice D. Cani
    Chapter 6. Therapeutic opportunities in the vaginal microbiome / Gregor Reid
    Chapter 7. Lung microbiota and its impact on the mucosal immune phenotype / Benjamin G. Wu, Leopoldo N. Segal
    Chapter 8. Microbiota, liver diseases, and alcohol / Anne-Marie Cassard, Philippe Gérard, Gabriel Perlemuter
    Chapter 9. The potential of probiotics as a therapy for osteoporosis / Fraser L. Collins, Naiomy D. Rios-Arce, Jonathan D. Schepper, Narayanan Parameswaran, Laura R. McCabe
    Chapter 10. Ecological therapeutic opportunities for oral diseases / Anilei Hoare, Philip D. Marsh, Patricia I. Diaz
    C. CONTROL OF INFECTIOUS DISEASE BY MICROBES. Chapter 11. Control of Clostridium difficile infection by defined microbial communities / James Collins, Jennifer M. Auchtung
    Chapter 12. Fecal microbiota transplantation : therapeutic potential for a multitude of diseases beyond Clostridium difficile / Guido J. Bakker, Max Nieuwdorp
    Chapter 13. Enterococci and their interactions with the intestinal microbiome / Krista Dubin, Eric G. Palmer
    D. NEXT-GENERATION MICROBIAL THERAPEUTICS: TOOLS AND REGULATION. Chapter 14. Engineering diagnostic and therapeutic gut bacteria / Brian P. Landry, Jeffrey J. Tabor
    Chapter 15. Use of traditional and genetically modified probiotics in human health : what does the future hold? / Luis G. Bermúdez-Humarán, Philippe Langella
    Chapter 16. Genetic tools for the enhancement of probiotic properties / Laura Ortiz-Velez, Robert Britton
    Chapter 17. Genome editing of food-grade lactobacilli to develop therapeutic probiotics / Jan-Peter van Pijkeren, Rodolphe Barrangou
    Chapter 18. United States regulatory considerations for development of live biotherapeutic products as drugs / Sheila M. Dreher-Lesnick, Scott Stibitz, Paul E. Carlson, Jr.
    E. INDIRECT STRATEGIES TO TARGET MICROBIOME FUNCTION FOR HEALTH. Chapter 19. Bacteriophage clinical use as antibacterial “drugs” : utility and precedent / Stephen T. Abedon
    Chapter 20. Modulation of the gastrointestinal microbiome with nondigestable fermentable carbohydrates to improve human health / Edward C. Deehan, Rebbeca M. Duar, Anissa M. Armet, Maria Elisa Perez-Muñoz, Mingliang Jin, Jens Walter.
    Digital Access Wiley 2018